TY  - JOUR
AU  - Rivera-Caravaca, José Miguel
AU  - Núñez-Gil, Iván J
AU  - Lip, Gregory Y H
AU  - Uribarri, Aitor
AU  - Viana-Llamas, María C
AU  - Gonzalez, Adelina
AU  - Castro-Mejía, Alex F
AU  - Alonso González, Berta
AU  - Alfonso, Emilio
AU  - García Prieto, Juan Fortunato
AU  - Cavallino, Chiara
AU  - Cortese, Bernardo
AU  - Feltes, Gisela
AU  - Fernández-Rozas, Inmaculada
AU  - Signes-Costa, Jaime
AU  - Huang, Jia
AU  - García Aguado, Marcos
AU  - Pepe, Martino
AU  - Romero, Rodolfo
AU  - Cerrato, Enrico
AU  - Becerra-Muñoz, Víctor Manuel
AU  - Raposeiras Roubin, Sergio
AU  - Santoro, Francesco
AU  - Bagur, Rodrigo
AU  - Sposato, Luciano
AU  - El-Battrawy, Ibrahim
AU  - López Masjuan, Alvaro
AU  - Fernandez-Ortiz, Antonio
AU  - Estrada, Vicente
AU  - Macaya, Carlos
AU  - Marín, Francisco
PY  - 2022
DO  - 10.1155/2022/7325060
UR  - http://hdl.handle.net/10668/20179
T2  - International journal of clinical practice
AB  - Most evidence regarding anticoagulation and COVID-19 refers to the hospitalization setting, but the role of oral anticoagulation (OAC) before hospital admission has not been well explored. We compared clinical outcomes and short-term prognosis between...
LA  - en
KW  - Administration, Oral
KW  - Anticoagulants
KW  - Atrial Fibrillation
KW  - Hemorrhage
KW  - Hospitalization
KW  - Hospitals
KW  - Humans
KW  - Prognosis
KW  - Registries
KW  - Thromboembolism
KW  - COVID-19 Drug Treatment
TI  - Chronic Oral Anticoagulation Therapy and Prognosis of Patients Admitted to Hospital for COVID-19: Insights from the HOPE COVID-19 Registry.
TY  - research article
VL  - 2022
ER  -